Considering the higher relative expression levels of erasers compared to writers in this in silico analysis, erasers FTO and ALKBH5 were further investigated in a separate (IPO Porto’s) RCC patient cohort, to evaluate the potential clinical significance of those findings. This evidence concerns the gene ALKBH5 and renal cell carcinoma.